The carrier rate of pathogenic CFTR gene mutations is approximately 4% in persons of northern European descent [15], indicating a more than fourfold higher prevalence of CF carriers in our cohort, which may be an underestimation since not all of the included patients were from high risk ethnic groups. The gene discussed is CFTR; the disease is cystic fibrosis.